Australian Biotechnologies

What Australian Biotechnologies does

Australian Biotechnologies Pty Ltd is an Australian specialist manufacturer and distributor of human tissue allograft products, operating from Frenchs Forest, New South Wales, with a TGA-licensed processing facility. The company produces bone grafts, soft tissue grafts and dental allografts covering orthopaedic, spinal, dental, plastic/reconstructive/oral-maxillofacial and urology/gynaecology surgical applications, and is the largest biological tissue processor in Australia by volume, producing more than 20,000 bone and tissue allograft products per year and over 150,000 cumulatively since its 2000 founding. Core technical differentiation sits in two proprietary processing technologies: NanoXposeTM, which exposes natural bone nanotopography while delivering bactericidal and virucidal effects, and PureCleanseTM, which uses supercritical CO2 to remove lipids and antigenic material without harsh chemicals or high heat, producing osteoconductive and osteoinductive matrices validated by batch-level TGA-nominee lot release testing.

The company monetises through B2B direct sales of allograft SKUs (including the Allovance and Oravance branded portfolios covering freeze-dried, frozen, fibre, putty and custom formats) to surgeons and hospitals, with quote-based per-unit pricing disclosed only to qualified healthcare professionals. Go-to-market is executed almost entirely through clinical-support channel partnerships: Stryker for orthopaedics, LifeHealthcare for spinal, Samson Medical Technologies for plastic/reconstructive/OMF and Henry Schein Halas for dental, each of which provides in-hospital clinical support and last-mile distribution. Procurement is supported by a 24-hour ordering line, an out-of-hours mobile contact and a restricted healthcare-practitioner portal. Raw input tissue is sourced via donation partnerships with the NSW Health Organ and Tissue Donation Service, the ACT Government / DonateLife programme, the Australian Tissue Donation Network and the Tissue Life Foundation, with Australian Biotechnologies processing over 6,500 allografts per year for NSW OTDS alone.

The business is privately held under a Pty Ltd structure, was founded by current CEO Simon Berry, employs 51–100 people, has raised no disclosed institutional funding, and operates in Australia and New Zealand only. Customer base is diffuse — hundreds of public and private hospitals and 125+ spinal surgeons reached via LifeHealthcare — with revenue not publicly disclosed.

Name

Australian Biotechnologies

Legal name

Australian Biotechnologies Pty Ltd

Website

https://ausbiotech.com.au

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

51–100 employees

Short description

Australian Biotechnologies is a TGA-licensed Australian manufacturer and distributor of human tissue allograft products, supplying bone, soft tissue and dental allografts to orthopaedic, spinal, dental and reconstructive surgeons across Australia and New Zealand via clinical-support channel partners.

Ownership category

akta.pro rank

Product category

Allograft Tissue Products (Bone and Soft Tissue Grafts)

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Bone Graft Substitutes & Orthobiologics (Synthetic/Allograft/DBM) (HLAHAEAG)

akta.pro secondary industries

Cartilage, Bone & Musculoskeletal Regeneration (HLAAAGAH), Dental Implant Surgery & Bone Grafting (HLABAEAB)

Keywords

• Allograft tissue products
• Bone graft biologics
• Orthopaedic surgical allografts
• Spinal fusion allografts
• Dental bone grafts

Headquarters

HQ city

Sutton Forest

HQ country

Australia

HQ region

Oceania

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Allograft Tissue Products: Australian Biotechnologies manufactures and distributes human tissue allograft products including bone grafts, tendons, and soft tissue for surgical applications. Revenue is generated through direct product sales to healthcare providers, hospitals, and surgeons. Products are supplied in various formats including frozen, freeze-dried, and processed allografts for orthopaedic, spinal, dental, and plastic/reconstructive surgeries.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels5 records

Core offering

Australian Biotechnologies manufactures and distributes human tissue allograft products for surgical applications, including bone grafts (cortical, cancellous, cortico-cancellous, granules, fibres, blocks, wedges), tendons, and soft tissue grafts. Products are supplied under the Allovance and Oravance brands in frozen, freeze-dried, and processed formats for orthopaedic, spinal, dental, plastic/reconstructive, oral maxillofacial, and urology/gynaecology surgery, processed using proprietary NanoXpose™ and PureCleanse™ technologies and distributed exclusively through clinical support partner organisations.

Product overview

Australian Biotechnologies is a specialist manufacturer and distributor of human tissue allograft products for medical use. The company operates as a single unified product portfolio of biological tissue products, organized across multiple product lines serving different surgical specialties. The core product families include the Allovance brand (encompassing Xpress, Freeze-Dried, Frozen, Crunch, CrunchPlus, FibrePutty, Fibres, FibreMat, and Fibre Boat variants), the Traditional Allograft range, Soft Tissue Allografts, Spinal Allografts, Oravance Dental Allografts, and Plastic/Reconstructive/Maxillofacial Allografts. Products are also available as Custom Allografts. These allografts are used in orthopaedic, spinal, dental, and oral-maxillofacial surgeries, processed using proprietary technologies including NanoXpose and PureCleanse. Clinical support services are provided through partnerships with Stryker (Orthopaedic), LifeHealthcare (Spinal), Samson Medical Technologies (Plastic/Reconstructive/OMF), and Henry Schein (Dental). The company is regulated by the TGA and has supplied over 150,000 allografts to the Australian community.

Differentiator

Problem solved

Functional benefit

Brands

• Allovance: Product brand for orthopaedic, spinal and osteoinductive allograft products including Xpress, Freeze-Dried, Frozen, Crunch, and Fibre product lines.
• Oravance

Products and services

• Allovance Xpress Freeze-dried allograft range packaged in an Xpress device for rapid hydration and easy handling. Exposes natural bone topography and provides optimal osteoconductive properties for orthopaedic surgeons performing bone void filling procedures. Includes Granules (Standard and Fine), Fibres, and Hybrid variants.
• Allovance Freeze-Dried Freeze-dried cancellous allografts in Sponge and Flex variants for various bone void filling applications, particularly revisional orthopaedic procedures. Products can be stored at room temperature.
• Allovance Frozen Frozen allograft range stored at -40°C in freezers supplied by Australian Biotechnologies or delivered on the same day in an esky on ice. Includes Crunch particles, Fibre products, Sponge, and cervical spacers in various sizes for spinal and orthopaedic applications.
• Allovance Crunch Osteoconductive bone particles processed with NanoXpose technology exposing natural nanotopography for rapid bone remodelling. Available in Fine (500-1000µm), Standard (1-3.5mm), and Large (3.5-8.0mm) sizes in 2.5g to 7.5g weights.
• Allovance CrunchPlus 100% bone allograft kit combining Allovance Crunch with Osteoinductive Fibre Mat. Provides excellent intraoperative handling properties and swells to conform to the surgical site. Super Critical Fluid (SCF CO2) treated for exposed nanotopography. Every batch independently tested for osteoinductivity. Available in Small (3g) and Medium (8.5g) sizes.
• Allovance FibrePutty 100% osteoinductive cortical microfibres in a flowable putty form. Every batch tested for osteoinductivity. Freeze-dried format stored at controlled ambient temperature. Used for grafting in expandable and 3D-printed cages, thorough filling of disc space, and challenging surgical situations.
• Spinal Allografts Range Spinal-specific allograft range for fusion procedures including Allovance Crunch, FibreMat, Sponge, Fibre Boat, FibreBag, FibreAnchors, cervical spacers, cancellous products, and femoral rings. Clinical support services provided by LifeHealthcare, giving Australian Biotechnologies access to over 125 spinal surgeons.
• Traditional Allografts Traditional bone allograft range including Femoral heads, Hemi-Femoral heads, Tibial/Humeral/Femoral shafts, Cortical/Cancellous struts and segments, HTO wedges, Cortico-Cancellous blocks, and Femoral rings. Supplied frozen.
• Soft Tissue Allografts Soft tissue allografts for orthopaedic applications including tendons with and without bone blocks: Gracilis Tendon, Semitendinosus Tendon, Peroneus Longus Tendon, Posterior Tibialis Tendon, Anterior Tibialis Tendon, Patella Tendon variants, and Achilles Tendon variants. Used in sports medicine procedures such as ACL/PCL reconstruction.
• Oravance Dental Allografts Dental-specific allograft range distributed by Henry Schein Halas. Includes Cortico-Cancellous, Pure Cortical, and Pure Cancellous bone granules in 0.5cc-2.0cc sizes, Cortical sheets, plates, blocks, and cancellous dowels. Provides optimal osteoconductivity for dental bone void filling in implant and augmentation procedures.
• Plastic, Reconstructive & Maxillofacial Allografts Allografts specifically designed for plastic, reconstructive, and oral maxillofacial surgery. Includes Unicortical Block, Fascia Lata, Costal Cartilage Segments, Allovance CrunchPlus, Allovance Xpress, and pre-shaped cortical products. Clinical support provided by Samson Medical Technologies.
• Urology and Gynaecology Allografts Allograft products for urology and gynaecology procedures. Includes Fascia Lata in various sizes (20mm x 100mm to 40mm x 160mm). Super Critical Fluid Treated, non-irradiated connective tissue sourced from lateral thigh.
• Custom Allografts (Orthopaedic and Spinal) Custom-designed allograft products manufactured to meet specific surgical requirements for orthopaedic and spinal applications. Orders can be placed via the 24-hour ordering line (1800 472 387 / 1800 GRAFTS).
• FibreAnchors Molded osteoinductive fibre plugs for bone grafting in spinal procedures. 100% cortical bone with no excipients. Available in Small (5.5-6.0mm screw), Medium (6.5-7.0mm screw), Large (7.5-8.0mm screw), and Extra-Large (8.5-9.0mm screw) sizes.

Quantifiable outcome

• Over 150,000 allografts supplied to the Australian community since founding in 2000
• +3 more outcomes

Named customers1 record

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• LifeHealthcarecoreChannel Partner/ Reseller/ Distributor · 1 October 2017Partnership with LifeHealthcare Group Limited to provide clinical, in-hospital support for the Australian Biotechnologies Spinal Allograft Range. LifeHealthcare acquired rights from Point Blank Medical Pty Ltd to provide clinical support services. The partnership provides LifeHealthcare entry into the bone repair allograft biologics market in Australia and gives Australian Biotechnologies access to over 125 spinal surgeons.
• StrykercoreChannel Partner/ Reseller/ DistributorStryker provides clinical support to Orthopaedic surgeons and their teams for the Australian Biotechnologies bone allograft range for orthopaedic applications. Stryker is a global medical technology company.
• Samson Medical TechnologiescoreChannel Partner/ Reseller/ DistributorSamson Medical Technologies provides innovative, clinically-proven medical and cosmetic technologies to the Australian and New Zealand markets. They focus on plastic, reconstructive and oral maxillofacial procedures and provide clinical support and distribution for Australian Biotechnologies products in this specialty area.
• Henry Schein HalascoreChannel Partner/ Reseller/ DistributorHenry Schein Halas distributes Oravance dental allograft products to Australian dental professionals. Henry Schein is a major distributor of healthcare products to dental practitioners.
• NSW Health Organ & Tissue Donation ServicecoreOthersNSW Health Organ & Tissue Donation Service (OTDS) operates the DonateLife program as part of the National Reform Program. Each year Australian Biotechnologies processes over 6,500 allografts on behalf of NSW OTDS.
• ACT Government | DONATE LIFEcoreOthersACT Government tissue donation agency working within required legal, procedural and ethical frameworks determined by the TGA for the provision of human tissue for transplant purposes.
• Australian Tissue Donation Network (ATDN)coreOthersATDN was formed to ensure development and delivery of education programs to facilitate tissue donation in NSW and greater Australia. They manage a successful Femoral Head Collection Program and have provided 1,000 femoral heads for allograft manufacturing.
• Tissue Life FoundationminorOthersOne of the government donation agencies that Australian Biotechnologies works with for the provision of human tissue for transplant purposes.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• MTF Biologics: One of the largest global tissue banks, providing allografts for orthopaedic, spinal, dental and reconstructive surgery. Directly comparable to Australian Biotechnologies as an allograft processor with multi-specialty product lines, but operating at significantly larger scale globally.
• LifeNet Health: US-based non-profit allograft processor offering bone, soft tissue, and dental allografts with proprietary processing technologies (e.g., Allowash, Preservon). Comparable to Australian Biotechnologies in product mix and processing-driven differentiation, but with global reach.
• AlloSource: US-based allograft tissue processor producing bone, skin, and soft tissue allografts for orthopaedic, spine, dental and wound care applications. Comparable in multi-specialty allograft portfolio and TGA-equivalent FDA regulatory model.
• Medtronic: Global spine and orthopaedics leader with significant bone graft substitute and biologic product lines (including INFUSE/BMP-2). Comparable as a competitor in spinal fusion grafts where Australian Biotechnologies sells osteoinductive allografts.
• DePuy Synthes (Johnson & Johnson MedTech): Orthopaedic and spine incumbent with a broad bone graft substitute portfolio including synthetic and biologic options. Competes with Australian Biotechnologies in orthopaedic and spinal graft slots, especially in trauma and joint reconstruction.
• Zimmer Biomet: Major orthopaedic reconstruction and biologics company offering bone graft substitutes and regenerative products. Comparable as a competitor in orthopaedic bone void filling and trauma repair segments served by Australian Biotechnologies.

Others

• Stryker: Global orthopaedic medical device incumbent that is simultaneously a distribution partner of Australian Biotechnologies and a competitor via its own biologics portfolio. Comparable as an orthopaedic channel and biologics competitor, but operates at much larger scale.
• LifeHealthcare Group: Australian/New Zealand medical device distributor and channel partner for Australian Biotechnologies' spinal allograft range. Comparable as a key distribution and clinical-support partner rather than direct product competitor; relevant for assessing channel risk.
• Henry Schein: Global dental and medical distributor that distributes Australian Biotechnologies' Oravance dental allograft products through Henry Schein Halas in Australia. Comparable as a channel partner and ecosystem participant in the dental allograft market.

Direct peers

• Geistlich Pharma: Swiss-based specialist in dental bone regeneration (Bio-Oss, Bio-Gide), a dominant bone graft substitute brand in dentistry. Directly comparable to Australian Biotechnologies' Oravance dental allograft line as a competitor in dental bone void filling and implant surgery.

Market position

Strengths5 records

Weaknesses3 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/2660592

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Australian Biotechnologies